Glembatumumab (anti-GPNMB) is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab (anti-GPNMB) can be coupled to the microtubule inhibitor monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an antibody-agent coupling (ADC) with antitumor activity.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
Specifictaions: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB175888-SCI_ab1aa474e3276f371127f8350f126952.pdf
- UPC:
- 51285307
- Condition:
- New
- Availability:
- 1 day
- Weight:
- 1.09 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab175888-1mg
- CAS:
- 1020264-78-1
- Product Size:
- 1mg